{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:56:20Z","timestamp":1790124980089,"version":"4.0.1"},"reference-count":66,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2022MH048"],"award-info":[{"award-number":["ZR2022MH048"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qilu Health Leading Talents Training Project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>AT-rich interaction domain 1A (ARID1A), is frequently mutated in cancer, leading to loss-of-function and posing challenges to therapeutic targeting. This study aimed to systematically explore epigenetic regulation of ARID1A, specifically promoter hypermethylation, in gastric cancer (GC) and its functional\/immunological consequences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We employed multi-omics bioinformatics analyses (UALCAN, cBioPortal, MEXPRESS and UCSC Xena) combined with\n                      <jats:italic>in vitro<\/jats:italic>\n                      functional validation in GC cell lines, including pharmacological demethylation using 5-Aza-2\u2019-deoxycytidine (5-aza-CdR) and mechanistic interrogation\n                      <jats:italic>via<\/jats:italic>\n                      AKT agonism (SC79).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Promoter hypermethylation was identified as a key mechanism silencing ARID1A transcriptional, showing a significant negative correlation between methylation\n                      <jats:italic>\u03b2<\/jats:italic>\n                      -values and mRNA expression (Spearman\u2019s\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u00a0=\u00a0\u00a0\u2212\u00a00.29,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a02.06\u00a0\u00d7\u00a010\n                      <jats:sup>\u22128<\/jats:sup>\n                      ). 5-aza-CdR treatment restored ARID1A expression (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0\u00a0&lt;\u00a0\u00a00.001), suppressed malignant phenotypes (proliferation, invasion, and apoptosis resistance), and revealed that ARID1A lose activates the phosphatidylinositol 3-kinase (PI3K)\/protein kinase B (AKT)\/mammalian target of rapamycin (mTOR) pathway (elevated p-AKT, p-mTOR) and upregulates PD-L1. Rescue experiments with SC79 reversed 5-aza-CdR\u2019s effects, confirming the ARID1A-PI3K\/AKT\/mTOR-PD-L1 axis. Integrative analysis linked ARID1A hypermethylation to elevated immune\/ESTIMATE scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0\u00a0&lt;\u00a0\u00a00.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ARID1A promoter hypermethylation drives an epigenetic-immune checkpoint cascade in GC. Combined with its association with immune signatures and PD-L1 upregulation, ARID1A hypermethylation emerges as a candidate biomarker for predicting immune checkpoint blockade (ICB) responsiveness and patient stratification in GC. Future studies should evaluate 5-aza-CdR-ICB-AKT inhibitor regimens in advanced models to guide clinical translation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7717\/peerj.20251","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:24:28Z","timestamp":1762417468000},"page":"e20251","source":"Crossref","is-referenced-by-count":7,"title":["Breaking epigenetic shackles: targeting ARID1A methylation and the PI3K\/AKT\/mTOR-PD-L1 axis to overcome immune escape in gastric cancer"],"prefix":"10.7717","volume":"13","author":[{"given":"Xueqin","family":"Duan","sequence":"first","affiliation":[{"name":"Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"},{"name":"Department of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingfa","family":"Huo","sequence":"additional","affiliation":[{"name":"Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"},{"name":"Department of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Qingdao Central Hospital of Health and Rehabilitation University, Qingdao,  Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Lan","sequence":"additional","affiliation":[{"name":"Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"},{"name":"Department of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Yang","sequence":"additional","affiliation":[{"name":"Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"},{"name":"Department of Medicine, Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhou","sequence":"additional","affiliation":[{"name":"Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"Suppl 3","key":"10.7717\/peerj.20251\/ref-1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1634\/theoncologist.10-90003-49","article-title":"Evolving chemotherapy for advanced gastric cancer","volume":"10","author":"Ajani","year":"2005","journal-title":"The Oncologist"},{"key":"10.7717\/peerj.20251\/ref-2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival: analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers during 2000\u20132014 from 322 population-based registries in 71 countries (CONCORD-3)","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.7717\/peerj.20251\/ref-3","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/cancers16112062","article-title":"ARID1A mutations in gastric cancer: a review with focus on clinicopathological features, molecular background and diagnostic interpretation","volume":"16","author":"Angelico","year":"2024","journal-title":"Cancer"},{"key":"10.7717\/peerj.20251\/ref-4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The gene ontology consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nature Genetics"},{"key":"10.7717\/peerj.20251\/ref-5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biology"},{"key":"10.7717\/peerj.20251\/ref-6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nature Medicine"},{"key":"10.7717\/peerj.20251\/ref-7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nature Reviews. Cancer"},{"key":"10.7717\/peerj.20251\/ref-8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research\u00a0Network","year":"2014","journal-title":"Nature"},{"key":"10.7717\/peerj.20251\/ref-9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.7717\/peerj.20251\/ref-10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Reports"},{"key":"10.7717\/peerj.20251\/ref-11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.3390\/cancers11091318","article-title":"PTEN alterations as a potential mechanism for tumor cell escape from PD-1\/PD-L1 inhibition","volume":"11","author":"Cretella","year":"2019","journal-title":"Cancer"},{"key":"10.7717\/peerj.20251\/ref-12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41420-025-02289-z","article-title":"Helicobacter pylori reduces METTL14-mediated VAMP3 m6A modification and promotes the development of gastric cancer by regulating LC3C-mediated c-Met recycling","volume":"11","author":"Cui","year":"2025","journal-title":"Cell Death Discovery"},{"key":"10.7717\/peerj.20251\/ref-13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"10.7717\/peerj.20251\/ref-14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/febs.15750","article-title":"Clinical advances in targeting epigenetics for cancer therapy","volume":"289","author":"Feng","year":"2022","journal-title":"The FEBS Journal"},{"key":"10.7717\/peerj.20251\/ref-15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Medicine"},{"key":"10.7717\/peerj.20251\/ref-16","doi-asserted-by":"publisher","first-page":"974346","DOI":"10.3389\/fimmu.2022.974346","article-title":"TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker","volume":"13","author":"Ge","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.20251\/ref-17","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1007\/s00204-025-04118-9","article-title":"An integrative multi-omics study to identify candidate DNA methylation biomarkers associated with gastric cancer prognosis","volume":"99","author":"Gu","year":"2025","journal-title":"Archives of Toxicology"},{"key":"10.7717\/peerj.20251\/ref-18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","article-title":"Siglec-9 regulates an effector memory CD8+ T-cell subset that congregates in the melanoma tumor microenvironment","volume":"7","author":"Haas","year":"2019","journal-title":"Cancer Immunology Research"},{"key":"10.7717\/peerj.20251\/ref-19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.7717\/peerj.20251\/ref-20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yexmp.2014.03.005","article-title":"Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer","volume":"96","author":"Hou","year":"2014","journal-title":"Experimental and Molecular Pathology"},{"key":"10.7717\/peerj.20251\/ref-21","doi-asserted-by":"publisher","first-page":"1332213","DOI":"10.3389\/fimmu.2023.1332213","article-title":"Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis","volume":"14","author":"Huang","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.20251\/ref-22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.1196333","article-title":"Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma","volume":"330","author":"Jones","year":"2010","journal-title":"Science"},{"key":"10.7717\/peerj.20251\/ref-23","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.20251\/ref-24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/labinvest.3780422","article-title":"Promoter methylation and silencing of PTEN in gastric carcinoma","volume":"82","author":"Kang","year":"2002","journal-title":"Laboratory Investigation"},{"key":"10.7717\/peerj.20251\/ref-25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/ijc.32140","article-title":"Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer","volume":"145","author":"Kim","year":"2019","journal-title":"International Journal of Cancer"},{"key":"10.7717\/peerj.20251\/ref-26","doi-asserted-by":"publisher","first-page":"W561","DOI":"10.1093\/nar\/gkz445","article-title":"MEXPRESS update 2019","volume":"47","author":"Koch","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.20251\/ref-27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.06.007","article-title":"Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids","volume":"518","author":"Koh","year":"2021","journal-title":"Cancer Letters"},{"key":"10.7717\/peerj.20251\/ref-28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7150\/ijbs.76345","article-title":"The developmental regulator HAND1 inhibits gastric carcinogenesis through enhancing ER stress apoptosis via targeting CHOP and BAK which is augmented by cisplatin","volume":"19","author":"Kuang","year":"2023","journal-title":"International Journal of Biological Sciences"},{"key":"10.7717\/peerj.20251\/ref-29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/cells12060952","article-title":"Targeting ARID1A-deficient cancers: an immune-metabolic perspective","volume":"12","author":"Lebedev","year":"2023","journal-title":"Cell"},{"key":"10.7717\/peerj.20251\/ref-30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","article-title":"Surgical management of gastric cancer: a review","volume":"157","author":"Li","year":"2022","journal-title":"JAMA Surgery"},{"key":"10.7717\/peerj.20251\/ref-31","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.20251\/ref-32","doi-asserted-by":"publisher","first-page":"e165673","DOI":"10.1172\/JCI165673","article-title":"Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models","volume":"133","author":"Li","year":"2023","journal-title":"The Journal of Clinical Investigation"},{"key":"10.7717\/peerj.20251\/ref-33","doi-asserted-by":"publisher","first-page":"8130","DOI":"10.1021\/acs.jafc.1c02620","article-title":"Isorhamnetin promotes MKN-45 gastric cancer cell apoptosis by inhibiting PI3K-mediated adaptive autophagy in a hypoxic environment","volume":"69","author":"Li","year":"2021","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"10.7717\/peerj.20251\/ref-34","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12967-024-05311-7","article-title":"Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma","volume":"22","author":"Li","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.7717\/peerj.20251\/ref-35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.semcancer.2020.11.018","article-title":"Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator","volume":"83","author":"Li","year":"2022","journal-title":"Seminars in Cancer Biology"},{"key":"10.7717\/peerj.20251\/ref-36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s12276-023-00926-0","article-title":"Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis","volume":"55","author":"Loe","year":"2023","journal-title":"Experimental & Molecular Medicine"},{"key":"10.7717\/peerj.20251\/ref-37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41419-023-05878-x","article-title":"Epigenetically modified AP-2\u03b1 by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression","volume":"14","author":"Long","year":"2023","journal-title":"Cell Death & Disease"},{"key":"10.7717\/peerj.20251\/ref-38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/0008-5472.CAN-18-2446","article-title":"ARID1A hypermethylation disrupts transcriptional homeostasis to promote squamous cell carcinoma progression","volume":"80","author":"Luo","year":"2020","journal-title":"Cancer Research"},{"key":"10.7717\/peerj.20251\/ref-39","doi-asserted-by":"publisher","first-page":"107499","DOI":"10.1016\/j.phrs.2024.107499","article-title":"ARID1A is a coactivator of STAT5 that contributes to CD8+ T cell dysfunction and anti-PD-1 resistance in gastric cancer","volume":"210","author":"Ma","year":"2024","journal-title":"Pharmacological Research"},{"key":"10.7717\/peerj.20251\/ref-40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-022-00856-5","article-title":"Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response","volume":"29","author":"Mandal","year":"2022","journal-title":"Journal of Biomedical Science"},{"key":"10.7717\/peerj.20251\/ref-41","doi-asserted-by":"publisher","first-page":"102287","DOI":"10.1016\/j.ctrv.2021.102287","article-title":"Targeting ARID1A mutations in cancer","volume":"100","author":"Mullen","year":"2021","journal-title":"Cancer Treatment Reviews"},{"key":"10.7717\/peerj.20251\/ref-42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nature Methods"},{"key":"10.7717\/peerj.20251\/ref-43","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"ELife"},{"key":"10.7717\/peerj.20251\/ref-44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10120-023-01373-6","article-title":"ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer","volume":"26","author":"Sato","year":"2023","journal-title":"Gastric Cancer"},{"key":"10.7717\/peerj.20251\/ref-45","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Research"},{"key":"10.7717\/peerj.20251\/ref-46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41591-018-0012-z","article-title":"ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade","volume":"24","author":"Shen","year":"2018","journal-title":"Nature Medicine"},{"key":"10.7717\/peerj.20251\/ref-47","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.mam.2022.101112","article-title":"Siglec receptors as new immune checkpoints in cancerSiglec","volume":"90","author":"Stanczak","year":"2023","journal-title":"Molecular Aspects of Medicine"},{"key":"10.7717\/peerj.20251\/ref-48","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1172\/JCI120612","article-title":"Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells","volume":"128","author":"Stanczak","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.7717\/peerj.20251\/ref-49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.7717\/peerj.20251\/ref-50","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.20251\/ref-51","doi-asserted-by":"publisher","first-page":"aaf1644","DOI":"10.1126\/science.aaf1644","article-title":"The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity","volume":"353","author":"Torres","year":"2016","journal-title":"Science (New York, N.Y.)"},{"key":"10.7717\/peerj.20251\/ref-52","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ng.982","article-title":"Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer","volume":"43","author":"Wang","year":"2011","journal-title":"Nature Genetics"},{"key":"10.7717\/peerj.20251\/ref-53","doi-asserted-by":"publisher","first-page":"e522","DOI":"10.1002\/ctm2.522","article-title":"Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/mTOR pathway","volume":"11","author":"Wang","year":"2021","journal-title":"Clinical and Translational Medicine"},{"key":"10.7717\/peerj.20251\/ref-54","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","article-title":"ARID1A mutations in endometriosis-associated ovarian carcinomas","volume":"363","author":"Wiegand","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.7717\/peerj.20251\/ref-55","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/biom13050736","article-title":"Epigenetic and tumor microenvironment for prognosis of patients with gastric cancer","volume":"13","author":"Wu","year":"2023","journal-title":"Biomolecules"},{"key":"10.7717\/peerj.20251\/ref-56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.acthis.2006.01.003","article-title":"Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance","volume":"108","author":"Wu","year":"2006","journal-title":"Acta Histochemica"},{"key":"10.7717\/peerj.20251\/ref-57","first-page":"799","article-title":"Mismatch repair deficiency and CpG island hypermethylation in sporadic colon adenocarcinomas","volume":"10","author":"Xiong","year":"2001","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.7717\/peerj.20251\/ref-58","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00204-015-1474-0","article-title":"Microsatellite instability: an update","volume":"89","author":"Yamamoto","year":"2015","journal-title":"Archives of Toxicology"},{"key":"10.7717\/peerj.20251\/ref-59","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nature Communications"},{"key":"10.7717\/peerj.20251\/ref-60","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.humpath.2014.08.007","article-title":"Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage","volume":"45","author":"Ye","year":"2014","journal-title":"Human Pathology"},{"key":"10.7717\/peerj.20251\/ref-61","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"10.7717\/peerj.20251\/ref-62","doi-asserted-by":"publisher","first-page":"e24437","DOI":"10.1002\/jcla.24437","article-title":"AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer","volume":"36","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.7717\/peerj.20251\/ref-63","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/jamaoncol.2016.2450","article-title":"Classification of advanced human cancers based on tumor immunity in the microenvironment (TIME) for cancer immunotherapy","volume":"2","author":"Zhang","year":"2016","journal-title":"JAMA Oncology"},{"key":"10.7717\/peerj.20251\/ref-64","doi-asserted-by":"publisher","first-page":"1533700","DOI":"10.3389\/fimmu.2025.1533700","article-title":"Combination of cadonilimab (PD-1\/CTLA-4 bispecific antibody) and apatinib as salvage therapy achieves partial response in MSI-H advanced gastric cancer: a case report","volume":"16","author":"Zhao","year":"2025","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.20251\/ref-65","doi-asserted-by":"publisher","first-page":"116086","DOI":"10.1016\/j.biopha.2023.116086","article-title":"Dual PI3K\/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU","volume":"170","author":"Zhong","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.7717\/peerj.20251\/ref-66","doi-asserted-by":"publisher","first-page":"4673153","DOI":"10.1155\/2020\/4673153","article-title":"Potential prognostic value and mechanism of stromal-immune signature in tumor microenvironment for stomach adenocarcinoma","volume":"2020","author":"Zhu","year":"2020","journal-title":"BioMed Research International"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/20251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20251.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20251.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:24:32Z","timestamp":1762417472000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/20251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":66,"alternative-id":["10.7717\/peerj.20251"],"URL":"https:\/\/doi.org\/10.7717\/peerj.20251","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"e20251"}}